Abiomed
ABMD
#1112
Rank
A$26.26 B
Marketcap
$582.51
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : A$0.23 Billion

According to Abiomed's latest financial reports the company's total liabilities are A$0.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31A$0.22 B4.72%
2021-03-31A$0.21 B-11.57%
2020-03-31A$0.24 B47.67%
2019-03-31A$0.16 B31.48%
2018-03-31A$0.12 B-1.86%
2017-03-31A$0.12 B78.44%
2016-03-31A$71.99 M17.79%
2015-03-31A$61.12 M52.75%
2014-03-31A$40.01 M26.6%
2013-03-31A$31.6 M18.82%
2012-03-31A$26.6 M2.26%
2011-03-31A$26.01 M10.2%
2010-03-31A$23.6 M-18.24%
2009-03-31A$28.87 M7.97%
2008-03-31A$26.74 M53.36%
2007-03-31A$17.43 M36.01%
2006-03-31A$12.82 M102.93%
2005-03-31A$6.31 M-1.35%
2004-03-31A$6.4 M-38.16%
2003-03-31A$10.35 M-45.83%
2002-03-31A$19.11 M-1.03%
2001-03-31A$19.31 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$4.59 B 1,816.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$26.17 B 10,822.64%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.22 B-4.28%๐Ÿ‡บ๐Ÿ‡ธ USA